BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37605288)

  • 1. Meta-analysis of
    Yu W; Zhao M; Deng Y; Liu S; Du G; Yan B; Zhao Z; Sun N; Guo J
    Cancer Imaging; 2023 Aug; 23(1):77. PubMed ID: 37605288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18 F-prostate specific membrane antigen positron emission tomography/computerized tomography for lymph node staging in medium/high risk prostate cancer: A systematic review and meta-analysis.
    Lv Z; Song L; Wang M; Hou H; Li H; Wang X; Wang J; Wang J; Liu M
    Chin Med J (Engl); 2024 Apr; 137(8):949-958. PubMed ID: 37690993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of
    Jiao M; Mingsong T; Hao J; Chunyin Z
    Hell J Nucl Med; 2023; 26(2):123-131. PubMed ID: 37527048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
    Lin CY; Lee MT; Lin CL; Kao CH
    Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of
    Chen R; Wang Y; Shi Y; Zhu Y; Xu L; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2970-2977. PubMed ID: 33528607
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zhou J; Wu R; Wang W; Zhao Y; Liu X
    Hell J Nucl Med; 2022; 25(3):297-311. PubMed ID: 36576728
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of
    Ling SW; de Jong AC; Schoots IG; Nasserinejad K; Busstra MB; van der Veldt AAM; Brabander T
    Eur Urol Open Sci; 2021 Nov; 33():61-71. PubMed ID: 34632423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
    Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Ren X; Nur Salihin Yusoff M; Hartini Mohd Taib N; Zhang L; Wang K
    Eur J Radiol; 2024 Jan; 170():111274. PubMed ID: 38147764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-To-Head Comparison of
    Zhao G; Ji B
    AJR Am J Roentgenol; 2022 Sep; 219(3):386-395. PubMed ID: 35441529
    [No Abstract]   [Full Text] [Related]  

  • 13. A Prospective Comparison of
    Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
    Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of
    Liu X; Wang Q; Zhang B; Jiang T; Zeng W
    Hell J Nucl Med; 2022; 25(1):88-102. PubMed ID: 35388806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wang R; Shen G; Yang R; Ma X; Tian R
    Eur J Radiol; 2020 Sep; 130():109131. PubMed ID: 32622250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis.
    Gossili F; Mogensen AW; Konnerup TC; Bouchelouche K; Alberts I; Afshar-Oromieh A; Zacho HD
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):281-294. PubMed ID: 37597010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity, Specificity, and Predictors of Positive
    Perera M; Papa N; Christidis D; Wetherell D; Hofman MS; Murphy DG; Bolton D; Lawrentschuk N
    Eur Urol; 2016 Dec; 70(6):926-937. PubMed ID: 27363387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.